HGF signaling impacts severity of Pseudomonas aeruginosa keratitis

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 4, 2014, Pages 2180-2190

  Jiang, Xiaoyu ^a   McClellan, Sharon A ^a   Barrett, Ronald ^a   Foldenauer, Megan ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; c met; HGF; IGF 1R; Keratitis; Mice

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 18; KERATINOCYTE GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; RECOMBINANT SCATTER FACTOR; RECOMBINANT SOMATOMEDIN C; S6 KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL KERATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SLIT LAMP; UPREGULATION;

BACTERIA; C-MET; HGF; IGF-1R; KERATITIS; MICE;

ANIMALS; CELLS, CULTURED; CORNEA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; KERATITIS; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84898453780     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13743     Document Type: Article

References (55)

1. Khatri S, Lass JH, Heinzel FP, et al. Regulation of endotoxininduced keratitis by PECAM-1, MIP-2, and Toll-like Receptor 4. Invest Ophthalmol Vis Sci. 2002;43:2278-2284.
2. Pachigolla G, Blomquist P, Cavanagh HD. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens. 2007;33:45-49.
3. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.
4. Zhou Z, Barrett RP, McClellan SA, et al. Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2008;49:4458-4467.
5. McClellan SA, Huang X, Barrett RP, van Rooijen N, Hazlett LD. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro-and anti-inflammatory cytokines in BALB/c mice. J Immunol. 2003;170:5219-5227.
6. Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Hazlett LD. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2007;48:797-807.
7. Weichhart T, Costantino G, Poglitsch M, et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity. 2008;29:565-577.
8. Baker AK, Wang R, Mackman N, Luyendyk JP. Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-α expression in macrophages by reducing IL-10 expression. Mol Immunol. 2009;46:2249-2255.
9. Cheekatla SS, Aggarwal A, Naik S. mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection. Med Microbiol Immunol. 2012;201:37-46.
10. Yang Q, Guan K. Expanding mTOR signaling. Cell Res. 2007; 17:666-681.
11. Hazlett LD, McClellan S, Kwon B, Barrett R. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest Ophthalmol Vis Sci. 2000;41:805-810.
12. Huang X, Hazlett LD. Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray. Invest Ophthalmol Vis Sci. 2003;44:3409-3416.
13. Suryawanshi A, Cao Z, Thitiprasert T, Zaidi TS, Panjwani N. Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology. J Immunol. 2013;190: 6397-6409.
14. Foldenauer ME, McClellan SA, Berger EA, Hazlett LD. mTOR regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection. J Immunol. 2013;190:5649-5658.
15. McClellan SA, Zhang Y, Barrett RP, Hazlett LD. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators down-regulated. Invest Ophthalmol Vis Sci. 2008;49:1502-1511.
16. Foldenauer ME, McClellan SA, Barrett RP, Zhang Y, Hazlett LD. Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea. Cornea. 2012;31:1176-1188.
17. Hong HS, Lee J, Lee EA, et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29+ stromallike cells. Nat Med. 2009;15:425-435.
18. Delgado AV, McManus AT, Chambers JP. Exogenous administration of substance P enhances wound healing in a novel skininjury model. Exp Biol Med (Maywood). 2005;230:271-280.
19. Hazlett LD, Moon MM, Strejc M, Berk RS. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28:1978-1985.
20. Jiang X, McClellan SA, Barrett RP, Berger EA, Zhang Y, Hazlett LD. VIP and growth factors in the infected cornea. Invest Ophthalmol Vis Sci. 2011;52:6154-6161.
21. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986-994.
22. Fortier AH. Isolation of murine macrophages. Curr Protoc Immunol. New York: John Wiley and Sons; 1994;14.11.11-14.11.16.
23. Bauer TW, Somico RJ, Fan F, et al. Regulatory role of c-met in insulin-like growth factor-1 receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol Cancer Ther. 2006;5:1676-1682.
24. Skrtic S, Wallenius K, Gressner AM, Jansson J-O. Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology. 1999;140: 5729-5735.
25. Nagano T, Nakamura M, Nakata K, et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci. 2003;44:3810-3815.
26. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
27. Matsumoto K, Hashimoto K, Yoshikawa K. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res. 1991;196:114-120.
28. Wilson SE, He YG, Weng J, Zieske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor on proliferation, motility, and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
29. Zelenka PS, Arpitha P. Coordinating cell proliferation and migration in the lens and cornea. Semin Cell Dev Biol. 2008; 19:113-124.
30. Wilson SE, Chen L, Mohan RR, Liang Q, Liu J. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res. 1999;68:377-397.
31. Wilson SE, Mohan RR, Mohan RR, Ambrósio R Jr, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20:625-637.
32. Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res. 2004;79:677-688.
33. Spix J, Chay EY, Block ER, Klarlund JK. Hepatocyte growth factor induces epithelial cell motility through transactivation of the epidermal growth factor receptor. Exp Cell Res. 2007; 313:3319-3325.
34. Carrington LE, Boulton M. Hepatocyte growth factor and keratinocyte growth factor regulation of epithelial and stromal corneal wound healing. J Cataract Refract Surg. 2005;31:412-423.
35. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
36. Li Q, Weng J, Mohan RR, et al. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci. 1996;37:727-739.
37. Lashkari K, Rahimi N, Kazlauskas A. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999;40:149-156.
38. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol. 2000;129:678-680.
39. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem. 1993;268:21212-21217.
40. Ueda T, Takeyama Y, Toyokawa A, Kishida S, Yamamoto M, Saitoh Y. Significant elevation of serum human hepatocyte growth factor levels in patients with acute pancreatitis. Pancreas. 1996;12:76-83.
41. Giebeler A, Brandenburg L, Kaldenbach M, et al. Lack of hepatic c-met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation. Lab Invest. 2012;92:1726-1737.
42. Huang X, Du W, McClellan SA, Barrett RP, Hazlett LD. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2006;47:4910-4916.
43. Shen Y, Naujokas M, Park M, Ireton K. InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell. 2000;103:501-510.
44. Cossart P. Met, the HGF-SF receptor: another receptor for Listeria monocytogenes. Trends Microbiol. 2001;9:105-107.
45. Franke R, Müller M, Wundack N, et al. Host-pathogen systems biology: logical modeling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction. BMC Syst Biol. 2008;2:4.
46. Churin YC, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the cmet receptor and enhances the motogenic response. J Cancer Biol. 2003;161:249-255.
47. Sugiyama A, Ogawa T, Daikuhara Y, Takada H. Enhancement of hepatocyte growth factor (scatter factor) production by human gingival fibroblasts in culture stimulated with Porphyromonas gingivalis fimbriae. J Med Microbiol. 2000;49:319-325.
48. Miyaso H, Morimoto Y, Ozaki M, et al. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes. J Gastroenterol Hepatol. 2005;20:1859-1866.
49. Fleiszig SM, Vallas V, Jun CH, et al. Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor. Infect Immun. 1998;66:3443-3446.
50. Berger EA, McClellan SA, Vistisen KS, Hazlett LD. HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog. 2013;9:e1003457.
51. Kovács KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux J. C/EBPβ couples dopamine signaling to substance P precursor gene expression in striatal neurons. J Neurochem. 2006;98:1390-1399.
52. Ido A, Moriuchi A, Numata M, et al. Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety. J Trans Med. 2011;9:55.
53. Yung HY, Joo HJ, Park JK, Kim YH. The blocking of c-met signaling induces apoptosis through the increase of p53 protein in lung cancer. Cancer Res Treat. 2012;44:251-261.
54. Kakazu A, Chandrasekher G, Bazan HE. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad-but not the ERK1/2-mediated signaling pathway. Invest Ophthalmol Vis Sci. 2004;45:3485-3492.
55. Riedemann J, Macaulay VM. IGF1R signaling and its inhibition. Endocr Relat Cancer. 2006;13:S33-S43.